# Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty

> **NCT00289601** · PHASE4 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 1200 (estimated)

## Conditions studied

- Angioplasty

## Interventions

- **DRUG:** eptifibatide

## Key facts

- **NCT ID:** NCT00289601
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 1200 (ESTIMATED)
- **Why stopped:** Sponsor support withdrawn
- **Last updated:** 2007-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00289601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00289601, "Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00289601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*